IMMUNOLOGICAL DETERMINATION OF PITUITARY LUTEINIZING HORMONE IN THE URINE OF FERTILE AND POST-MENOPAUSAL WOMEN AND ADULT MEN

1962 ◽  
Vol 39 (4) ◽  
pp. 539-546 ◽  
Author(s):  
Leif Wide ◽  
Carl Gemzell

ABSTRACT An immunological method to assay human pituitary luteinizing hormone (HPLH) in urine is described. It is based on the fact that HPLH crossreacts with human chorionic gonadotrophin (HCG) in an haemagglutination inhibition reaction between HCG-coated blood cells and rabbit HCG-antisera. During the menstrual cycle the excretion of HPLH reached a peak of 200–400 U per liter at the time of ovulation. In the urine of post-menopausal women the concentration of HPLH was between 100 and 400 U per liter. In the urine of adult men the concentration of HPLH was between 50 and 160 U per liter.

1969 ◽  
Vol 7 (9) ◽  
pp. 33-35

The three substances now used to stimulate the gonads in infertility are human follicle stimulating hormone (HFSH) obtained mainly from post-menopausal urine, but also from human pituitary glands, human chorionic gonadotrophin (HCG) extracted from the urine of pregnant women, and clomiphene (Clomid - Merrell), a synthetic compound which we reviewed in 1967.1


1976 ◽  
Vol 10 (2) ◽  
pp. 87-91 ◽  
Author(s):  
B. M. Hobson

A haemagglutination inhibition test, developed specifically for primates, diagnoses early pregnancy in the chimpanzee, gorilla, orang-utan and baboon. The test was sensitive and reacted positively when the concentration of gonadotrophin in urine was equivalent to 0·03 i.u. human chorionic gonadotrophin per ml. This degree of sensitivity and the certitude that it cross-reacts with primate luteinizing hormone probably accounts for most of the false positive results.


1966 ◽  
Vol 53 (3) ◽  
pp. 420-428 ◽  
Author(s):  
C. Robyn ◽  
P. O. Hubinont ◽  
E. Diczfalusy

ABSTRACT Immunologically mono-specific antisera prepared against human chorionic gonadotrophin (HCG) preparations completely neutralized in vitro as well as in vivo the luteinizing hormone (LH) and also the follicle-stimulating hormone (FSH) activity of both human hypophyseal gonadotrophin (HHG) and human menopausal gonadotrophin (HMG) preparations.


1961 ◽  
Vol 37 (3) ◽  
pp. 445-449 ◽  
Author(s):  
Leif Wide ◽  
Paul Roos ◽  
Carl Gemzell

ABSTRACT Human pituitary LH inhibits an haemagglutination reaction between anti-HCG-sera and HCG-coated blood cells. This immunological technique can be used for quantitative and qualitative estimation of human pituitary LH and of LH in human urine, provided no chorionic gonadotrophin is present.


1969 ◽  
Vol 45 (4) ◽  
pp. 505-513 ◽  
Author(s):  
B. G. ENGLAND ◽  
W. C. FOOTE ◽  
D. H. MATTHEWS ◽  
ARMANDO G. CARDOZO ◽  
S. RIERA

SUMMARY Results in 53 llamas (33 mated animals and 20 controls) showed that ovulation is copulation-induced in this species. Ovulation without copulation occasionally occurred during the height of the recognized breeding season in Bolivia. The first mating during the luteal phase (12–24 days after the preceding ovulation) resulted in ovulation in four out of ten llamas. Determination of pituitary luteinizing hormone (LH) content showed the highest level on the day before mating (9·00 μg./mg.) and the lowest level on day 4 (6·25 μg./mg.). LH level on day 8 was significantly higher than on day 4 (7·62 μg./mg.). Corpora lutea (c.l.) were well formed on day 4 after mating (408 mg.), reached a maximum size by day 8 (1920 mg.) and rapidly decreased in size to day 16 (136 mg.). The corpus albicans remained as an entity but decreased in size to 21 mg. on day 120. Similar changes were found in c.l. histology and progesterone content. The combined results indicate that the functional life of the c.l. in a non-pregnant llama is 16 days or less. Treatment with 25 i.u. human chorionic gonadotrophin was sufficient to cause ovulation in 50% of the animals treated. A large (150 mg.) dose of norethandrolone did not cause morphological regression of the c.l. when measured 5 days after treatment. Treatment with 5 mg. daily for 14 days caused regression of c.l. as compared with untreated controls and animals treated with oestradiol valerate.


1975 ◽  
Vol 152 (2) ◽  
pp. 365-372 ◽  
Author(s):  
Thomas A. Bramley

Treatment of mice aged 23–25 days with chorionic gonadotrophin induced large amounts of an ovarian alkaline phosphatase activity (phosphatase Ib) kinetically distinct from that of untreated ovaries (phosphatase I). The activities of alkaline phosphatase I and Ib varied with age in untreated mice. Phosphatase Ib appeared when serum luteinizing hormone concentrations increased (days 4–10 and days 35–45), and disappeared when concentrations were low (days 11–35). Injection of human chorionic gonadotrophin induced progressively larger amounts of phosphatase Ib activity between day 19 and day 29. However, gonadotrophin treatment failed to induce this activity on days 10–18 and 30–35. Nevertheless, during the latter period, human chorionic gonadotrophin induced especially large increases in uterine weight. Treatment at different ages with sheep luteinizing hormone plus human pituitary follicle-stimulating hormone induced a pattern of response identical with that induced by human chorionic gonadotrophin, although sheep luteinizing hormone alone was ineffective before 35 days. In contrast, human luteinizing hormone induced a response in the absence of exogenous follicle-stimulating hormone.


1964 ◽  
Vol 46 (4) ◽  
pp. 632-638 ◽  
Author(s):  
Bruce Hobson ◽  
Leif Wide

ABSTRACT When assayed against the International Standard for HCG the biological activity, as measured by the rat seminal vesicle method, of urines from women collected during the second half of pregnancy is lower than the immunological activity (haemagglutination inhibition reaction). Almost 100 % of the immunological and biological HCG activities were recovered from the acetone precipitates of such urines. A kaolin extract of these urines produced a partial separation of the immunological activity. About half of the immunological activity and almost all of the biological activity was recovered in the concentrate. In the supernatant, left after kaolin extraction, an immunologically active biologically inactive »HCG« was found. A urine from a woman with a hydatidiform mole was assayed by both methods. The biological and immunological activities of this urine were almost unity and the ratio of the 2 activities remained unaltered in the acetone precipitate and the kaolin concentrate made from an aliquot of this urine. The kaolin supernatant contained equal and measurable amounts of the biological and immunological activities. In conclusion the method used to concentrate the urine of pregnant women will affect the ratio between the biological activity and the immunological HCG activity.


1976 ◽  
Vol 81 (3) ◽  
pp. 605-615 ◽  
Author(s):  
John A. Salmon ◽  
K. L. Peh ◽  
S. S. Ratnam

ABSTRACT Six patients who had hydatidiform mole and who subsequently developed clinical choriocarcinomas were studied. Serial plasma samples were assayed for HCG content by (i) haemagglutination-inhibition test (HI test), (ii) a non-specific radioimmunoassay and (iii) a specific radioimmunoassay developed against the β-sub unit of HCG. When levels of HCG were high all three assays gave results which parallelled each other. However, the radioimmunoassays were able to detect the presence of HCG several weeks after the HI test became negative. Luteinizing hormone cross-reacted in the non-specific radioimmunoassay of HCG and may lead to false positive results. The present study indicated that it is important to employ the radioimmunoassay against the β-sub unit of HCG to permit a specific assessment of HCG activity and thereby provide a reliable monitoring of patients following hydatidiform mole or with choriocarcinoma.


Sign in / Sign up

Export Citation Format

Share Document